Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.13.18 - cytosol nonspecific dipeptidase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
Prolidase and prolinase activities in moderately and poorly differentiated lung adenocarcinoma.
Adenocarcinoma of Lung
Prolidase and prolinase activities in moderately and poorly differentiated lung adenocarcinoma.
Carcinoma
Quantitative proteomics approach to screening of potential diagnostic and therapeutic targets for laryngeal carcinoma.
Carcinoma, Hepatocellular
Effect of ethanol on prolidase I and prolinase activity in the human hepatoma cell line Hep G2.
Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Colonic Neoplasms
Up-regulation of CNDP2 facilitates the proliferation of colon cancer.
Diabetes Mellitus, Type 1
Exclusion of polymorphisms in carnosinase genes (CNDP1 & CNDP2) as cause of diabetic nephropathy in type 1 diabetes mellitus. Results of large case - control and follow - up studies.
Diabetes Mellitus, Type 2
Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.
Diabetic Nephropathies
Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.
Exclusion of polymorphisms in carnosinase genes (CNDP1 & CNDP2) as cause of diabetic nephropathy in type 1 diabetes mellitus. Results of large case - control and follow - up studies.
Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.
Fibrosarcoma
Activity of lysosomal and nonlysosomal proteases of fibrosarcoma induced by methylcholanthrene.
Hepatitis, Chronic
Determination of prolinase activity in plasma. Application to liver disease and its relation with prolidase activity.
Infections
Changes in the intestinal enzyme activity of lambs during chronic infection with Trichostrongylus vitrinus.
Liver Diseases
Determination of prolinase activity in plasma. Application to liver disease and its relation with prolidase activity.
Liver Diseases, Alcoholic
Plasma prolidase and prolinase activity in alcoholic liver disease.
Neoplasm Metastasis
CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway.
Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Quantitative proteomics approach to screening of potential diagnostic and therapeutic targets for laryngeal carcinoma.
Neoplasms
A toolset to study functions of Cytosolic non-specific dipeptidase 2 (CNDP2) using Drosophila as a model organism.
Activity of lysosomal and nonlysosomal proteases and contents of protein and its degradation products in the blood serum of rats with fibrosarcoma induced by methylcholanthrene.
Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway.
Obesity
The Combined Effects of Genetic Variation in the CNDP1 and CNDP2 Genes and Dietary Carbohydrate and Carotene Intake on Obesity Risk.
Ovarian Neoplasms
CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway.
Parkinson Disease
Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease.
Prolidase Deficiency
Biochemical investigations on prolidase and prolinase in erythrocytes from patients with prolidase deficiency.
Characteristics and partial purification of prolidase and prolinase from leukocytes of a normal human and a patient with prolidase deficiency.
Characteristics of prolinase against various iminodipeptides in erythrocyte lysates from a normal human and a patient with prolidase deficiency.
Plasma prolidase and prolinase activity in prolidase deficiency.
Prolinase activity in prolidase-deficient fibroblasts.
Stomach Neoplasms
Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway.
Uremia
Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia.
xaa-pro dipeptidase deficiency
Biochemical investigations on prolidase and prolinase in erythrocytes from patients with prolidase deficiency.
Characteristics and partial purification of prolidase and prolinase from leukocytes of a normal human and a patient with prolidase deficiency.
Characteristics of prolinase against various iminodipeptides in erythrocyte lysates from a normal human and a patient with prolidase deficiency.
Plasma prolidase and prolinase activity in prolidase deficiency.
Prolinase activity in prolidase-deficient fibroblasts.